We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you accept our Privacy Policy and Terms of Service, revised from time to time, and you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties. You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Countdown to International Flavors (IFF) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
Read MoreHide Full Article
Wall Street analysts expect International Flavors (IFF - Free Report) to post quarterly earnings of $0.78 per share in its upcoming report, which indicates a year-over-year increase of 8.3%. Revenues are expected to be $2.67 billion, down 1.4% from the year-ago quarter.
The consensus EPS estimate for the quarter has been revised 2.5% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
With that in mind, let's delve into the average projections of some International Flavors metrics that are commonly tracked and projected by analysts on Wall Street.
According to the collective judgment of analysts, 'Net Sales- Nourish' should come in at $1.37 billion. The estimate suggests a change of -1.6% year over year.
Based on the collective assessment of analysts, 'Net sales- Scent' should arrive at $555.31 million. The estimate points to a change of -3.9% from the year-ago quarter.
The consensus among analysts is that 'Net Sales- Pharma Solutions' will reach $206.76 million. The estimate indicates a change of +1.9% from the prior-year quarter.
Analysts forecast 'Net Sales- Health & Biosciences' to reach $532.95 million. The estimate suggests a change of +0.9% year over year.
The consensus estimate for 'Adjusted Operating EBITDA- Nourish' stands at $167.93 million. Compared to the current estimate, the company reported $165 million in the same quarter of the previous year.
Analysts expect 'Adjusted Operating EBITDA- Pharma Solutions' to come in at $31.04 million. The estimate compares to the year-ago value of $26 million.
Analysts' assessment points toward 'Adjusted Operating EBITDA- Scent' reaching $103.11 million. Compared to the current estimate, the company reported $108 million in the same quarter of the previous year.
The collective assessment of analysts points to an estimated 'Adjusted Operating EBITDA- Health & Biosciences' of $150.64 million. The estimate compares to the year-ago value of $162 million.
Over the past month, International Flavors shares have recorded returns of +0.6% versus the Zacks S&P 500 composite's +3.9% change. Based on its Zacks Rank #3 (Hold), IFF will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Countdown to International Flavors (IFF) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
Wall Street analysts expect International Flavors (IFF - Free Report) to post quarterly earnings of $0.78 per share in its upcoming report, which indicates a year-over-year increase of 8.3%. Revenues are expected to be $2.67 billion, down 1.4% from the year-ago quarter.
The consensus EPS estimate for the quarter has been revised 2.5% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
With that in mind, let's delve into the average projections of some International Flavors metrics that are commonly tracked and projected by analysts on Wall Street.
According to the collective judgment of analysts, 'Net Sales- Nourish' should come in at $1.37 billion. The estimate suggests a change of -1.6% year over year.
Based on the collective assessment of analysts, 'Net sales- Scent' should arrive at $555.31 million. The estimate points to a change of -3.9% from the year-ago quarter.
The consensus among analysts is that 'Net Sales- Pharma Solutions' will reach $206.76 million. The estimate indicates a change of +1.9% from the prior-year quarter.
Analysts forecast 'Net Sales- Health & Biosciences' to reach $532.95 million. The estimate suggests a change of +0.9% year over year.
The consensus estimate for 'Adjusted Operating EBITDA- Nourish' stands at $167.93 million. Compared to the current estimate, the company reported $165 million in the same quarter of the previous year.
Analysts expect 'Adjusted Operating EBITDA- Pharma Solutions' to come in at $31.04 million. The estimate compares to the year-ago value of $26 million.
Analysts' assessment points toward 'Adjusted Operating EBITDA- Scent' reaching $103.11 million. Compared to the current estimate, the company reported $108 million in the same quarter of the previous year.
The collective assessment of analysts points to an estimated 'Adjusted Operating EBITDA- Health & Biosciences' of $150.64 million. The estimate compares to the year-ago value of $162 million.
View all Key Company Metrics for International Flavors here>>>
Over the past month, International Flavors shares have recorded returns of +0.6% versus the Zacks S&P 500 composite's +3.9% change. Based on its Zacks Rank #3 (Hold), IFF will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>